B

BNTX

BNTX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
BNTX Live QuoteReal-time
$81.38
$9.91(-10.86%)1M
Day Range$80.81 – $84.29
Open$83.00
Previous Close$83.26
Volume1.50M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$20.64B
P/E Ratio (TTM)24.5
Forward P/E7.0
EPS (TTM)$-6.83
Price to Book1.1
Dividend Yield0.65%
Beta (Volatility)1.33
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $81.38 (4%)
Low: $79.52High: $124.00
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$111.81-25.5% upside

Insider Buys

0

$0

Insider Sales

3

$19.34M

Total Volume

$19.34M

3 transactions

Net Activity

$19.34M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Sahin Ugur

CEO, 10%

0 buys3 sells

$19.34M total

Trading History
BNTX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 29, 2026

1 months ago

Sahin Ugur

CEO, 10%

CEO
Sell66.0K$98.19$6.48M

Sep 25, 2026

1 months ago

Sahin Ugur

CEO, 10%

CEO
Sell61.0K$98.57$6.01M

Sep 23, 2026

1 months ago

Sahin Ugur

CEO, 10%

CEO
Sell69.0K$99.17$6.84M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BNTX Buy Conviction0%
Industry Rank#0 of 570
Volume Contribution0.1%
Total Industry Activity$16.44B

BNTX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BNTX

Over the last 90 days, corporate insiders at BNTX (BNTX) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $19.34M.

The net insider activity for BNTX shows a net selling bias of $19.34M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Sahin Ugur (CEO, 10%), who traded 69.0K shares valued at $6.84M on Sep 23, 2026.

Live Market News & Developments
Aggregated real-time headlines for BNTX (BNTX)
6 updates

BioNTech (BNTX) Stock Looks Fully Valued As Sales Face Pressure

Yahoo Finance6d ago

BNTX Stock Price and Chart — NASDAQ:BNTX

TradingView57d ago

BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.

Barron's6d ago

BioNTech: Priority Review Voucher Purchase Hints At Much Needed Approval Shot

Seeking Alpha2d ago

Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?

The Motley Fool32d ago

Trading the Move, Not the Narrative: (BNTX) Edition

Stock Traders DailyYesterday

FAQs About BNTX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BNTX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BNTX is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for BNTX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.